Cure Alzheimer’s Fund Interview Series:
Charles Glabe, Ph.D.

Posted September 2, 2025

Join us as we learn about the personal reflections from scientists funded by Cure Alzheimer’s Fund and gain a direct window into their motivations and challenges that drive Alzheimer's research today.

CureAlz is honored to present Dr. Charles Glabe, whose pioneering antibody research has advanced the detection of Alzheimer’s disease and opened new paths toward treatment.

Dr. Glabe is a member of the CureAlz Research Leadership Group.
Learn here about his work supported by CureAlz.

News Updates Videos

Cure Alzheimer’s Fund Interview Series:
Shane A. Liddelow, Ph.D.

Back to News and Events

Cure Alzheimer’s Fund Interview Series:
Riqiang Yan, Ph.D.

Related Content:

Webinar: Alzheimer’s Disease:
Hope on the Horizon and What Can You Do Now to Lower Your Risk

Webinar: How to Give With Purpose and Make Your Impact Last: A Conversation With Patricia Annino

CURE ALZHEIMER’S FUND AWARDS 1,000TH RESEARCH GRANT

Cure Alzheimer’s Fund Receives $50 Million Gift to Support Research

CureAlz Panel Discussion:
Sunset and the Mockingbird

Cure Alzheimer’s Fund Names New
Executive Vice President for Research Management